Clinical Trials · NCT02320045
Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Intarcia Therapeutics
- Enrollment
- 38
- Start date
- Nov 2014
- Locations
- 4 sites, United States, Germany
- Primary endpoint
- 24-h Area under the Curve at steady state (AUCt,ss)